Next Article in Journal
Caffeic Acid–Chicoric Acid (1:1) Mixture Exerts Antioxidant Effects and Regulates Intestinal Health in Oxazolone-Induced Zebrafish
Previous Article in Journal
Temporal Phenolic Profile and Bioactivity of Endemic Salvia transsylvanica (Transylvanian Sage) During Flowering
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antioxidants
Volume 15
Issue 4
10.3390/antiox15040418
Due to scheduled maintenance work on our servers, there may be short service disruptions on this website between 11:00 and 12:00 CEST on March 28th.
antioxidants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Antioxidants 2021, 10(3), 372.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Seol et al. Taurine Protects Against Postischemic Brain Injury via the Antioxidant Activity of Taurine Chloramine. Antioxidants 2021, 10, 372

by
Song-I Seol
1,2,
Hyun Jae Kim
2,3,
Eun Bi Choi
2,3,
In Soon Kang
3,
Hye-Kyung Lee
1,
Ja-Kyeong Lee
1,2,* and
Chaekyun Kim
2,3,4,*
1
Department of Anatomy, Inha University School of Medicine, Incheon 22212, Republic of Korea
2
BK21, Program in Biomedical Science & Engineering, Inha University, Incheon 22212, Republic of Korea
3
Laboratory of Leukocyte Signaling Research, Department of Pharmacology, Inha University School of Medicine, Incheon 22212, Republic of Korea
4
Convergent Research Center for Metabolism and Immunoregulation, Inha University, Incheon 22212, Republic of Korea
*
Authors to whom correspondence should be addressed.
Antioxidants 2026, 15(4), 418; https://doi.org/10.3390/antiox15040418
Submission received: 3 February 2026 / Accepted: 5 February 2026 / Published: 27 March 2026
Browse Figure
Versions Notes
In the original publication [1], there was a mistake in Figure 1C. The image representing the −1 h (pre-treatment) group was mistakenly duplicated from the +4 h (post-treatment) group. The image at the +4 h point is correct; however, the image at the −1 h point was incorrectly placed during figure assembly.
We have prepared a corrected Figure 1 and its legend (below). This figure incorporates the correct image for the −1 h group, selected from our original four images available for this experimental group. Additionally, to enhance clarity and avoid unnecessary repetition, we have simplified Figure 1C,D by removing redundant images, as all TTC images in these panels originated from the same set of experiments.
We confirmed that no changes had been made to the Results section in the manuscript. The data displayed in the corrected figure panels were already used for the statistical analysis, and we have confirmed that all statistics are correct. The authors confirm that this correction does not affect the scientific conclusions of the article. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Seol, S.-I.; Kim, H.J.; Choi, E.B.; Kang, I.S.; Lee, H.-K.; Lee, J.-K.; Kim, C. Taurine Protects against Postischemic Brain Injury via the Antioxidant Activity of Taurine Chloramine. Antioxidants 2021, 10, 372. [Google Scholar] [CrossRef] [PubMed]
Antioxidants 15 00418 g001
Figure 1. Tau-Cl suppressed infarct formation in the postischemic brain. (A,B) Tau-Cl (0.1, 0.5, 1 or 2 mg/kg) or taurine (0.5 or 1 mg/kg) was administered intranasally at 1 h post-middle cerebral artery occlusion (MCAO) and 2,3,5-triphenyl tetrazolium chloride (TTC) staining was carried out at 2 days post-MCAO. (C,D) Tau-Cl (0.5 mg/kg) was administered intranasally at 1 h prior to or 4 h post-MCAO, and TTC staining was carried out at 2 days post-MCAO. Representative images of infarctions are shown (A,C), and mean infarction volumes are presented as mean ± SEM (n = 4–10) (B,D). Figure 1C shares the same control group as Figure 1A. Sham—sham-operated rats (n = 4); MCAO—phosphate-buffered saline (PBS)-treated MCAO control (n = 10); MCAO + Tau-Cl—Tau-Cl-treated MCAO rats (n = 33); MCAO + taurine—taurine-treated MCAO rats (n = 8). * p < 0.05, ** p < 0.01 vs. PBS-treated MCAO control by one-way ANOVA with Student–Newman–Keuls test.
Figure 1. Tau-Cl suppressed infarct formation in the postischemic brain. (A,B) Tau-Cl (0.1, 0.5, 1 or 2 mg/kg) or taurine (0.5 or 1 mg/kg) was administered intranasally at 1 h post-middle cerebral artery occlusion (MCAO) and 2,3,5-triphenyl tetrazolium chloride (TTC) staining was carried out at 2 days post-MCAO. (C,D) Tau-Cl (0.5 mg/kg) was administered intranasally at 1 h prior to or 4 h post-MCAO, and TTC staining was carried out at 2 days post-MCAO. Representative images of infarctions are shown (A,C), and mean infarction volumes are presented as mean ± SEM (n = 4–10) (B,D). Figure 1C shares the same control group as Figure 1A. Sham—sham-operated rats (n = 4); MCAO—phosphate-buffered saline (PBS)-treated MCAO control (n = 10); MCAO + Tau-Cl—Tau-Cl-treated MCAO rats (n = 33); MCAO + taurine—taurine-treated MCAO rats (n = 8). * p < 0.05, ** p < 0.01 vs. PBS-treated MCAO control by one-way ANOVA with Student–Newman–Keuls test.
Antioxidants 15 00418 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Seol, S.-I.; Kim, H.J.; Choi, E.B.; Kang, I.S.; Lee, H.-K.; Lee, J.-K.; Kim, C. Correction: Seol et al. Taurine Protects Against Postischemic Brain Injury via the Antioxidant Activity of Taurine Chloramine. Antioxidants 2021, 10, 372. Antioxidants 2026, 15, 418. https://doi.org/10.3390/antiox15040418

AMA Style

Seol S-I, Kim HJ, Choi EB, Kang IS, Lee H-K, Lee J-K, Kim C. Correction: Seol et al. Taurine Protects Against Postischemic Brain Injury via the Antioxidant Activity of Taurine Chloramine. Antioxidants 2021, 10, 372. Antioxidants. 2026; 15(4):418. https://doi.org/10.3390/antiox15040418

Chicago/Turabian Style

Seol, Song-I, Hyun Jae Kim, Eun Bi Choi, In Soon Kang, Hye-Kyung Lee, Ja-Kyeong Lee, and Chaekyun Kim. 2026. "Correction: Seol et al. Taurine Protects Against Postischemic Brain Injury via the Antioxidant Activity of Taurine Chloramine. Antioxidants 2021, 10, 372" Antioxidants 15, no. 4: 418. https://doi.org/10.3390/antiox15040418

APA Style

Seol, S.-I., Kim, H. J., Choi, E. B., Kang, I. S., Lee, H.-K., Lee, J.-K., & Kim, C. (2026). Correction: Seol et al. Taurine Protects Against Postischemic Brain Injury via the Antioxidant Activity of Taurine Chloramine. Antioxidants 2021, 10, 372. Antioxidants, 15(4), 418. https://doi.org/10.3390/antiox15040418

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop